The theory of the sick lobe

Breast Cancer: A Lobar Disease

Volumn , Issue , 2008, Pages 1-17

  Tot, Tibor ^a  

^a FALUN HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892210831     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84996-314-5_1     Document Type: Chapter

References (97)

1. Agelopoulos K, Buerger H, Brandt B (2008) Allelic imbalance of the egfr gene as key event in breast cancer progression - the concept of committed progenitor cells. Curr Cancer Drug Targets 8:431-445
2. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identifcation of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988
3. Andersen JA, Blichert-Toft M, Dyreborg U (1987) In situ carcinomas of the breast. Types, growth pattern, diagnosis and treatment. Eur J Surg Oncol 13:105-111
4. Asioli S, Eusebi V, Gaetano L, Losi L, Bussolati G (2008) The pre-lymphatic pathway, the roots of the lymphatic system in the breast tissue: a 3D study. Virchows Arch 453:401-406
5. Baik I, Becker PS, Devito WJ, Lagiou P, Ballen K, Quesenberry PJ, Hsiech CC (2004) Stem cells and prenatal origin of breast cancer. Cancer Causes Control 15:517-530
6. Boecker W, Burger H (2003) Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium: a new progenitor (adult stem cell) concept. Cell Prolif 36(Suppl 1):73-84
7. Boyle P, Ferlay J (2005) Cancer incidence and mortality in Europe 2004. Ann Oncol 16(3):481-488
8. Buell P (1973) Changing incidence in breast cancer in Japanese-American women. J Natl Cancer Inst 51:1479-1483
9. Buerger H, Otterbach F, Simon R, Poremba C, Diallo R, Decker T, Reithdorf L, Brinkschmidt C, Dockhorn-Deorniczak B, Boecker W (1999) Comparative genomic hybridization of ductal carcinoma in situ of the breast - evidence of multiple genetic pathways. J Pathol 187:396-402
10. Cardiff RD, Wellings SR (1999) The comparative pathology of human and mouse mammary glands. J Mammary Gland Biol Neoplasia 4:105-122
11. Cariati M, Purushotham AD (2008) Stem cells and breast cancer. Histopathology 52:99-107
12. Cerhan JR, Sellers TA, Janney CA, Pankratz VS, Brandt KR, Vachon CM (2005) Prenatal and perinatal correlates of adult mammographic breast densities. Cancer Epidemiol Biomarkers Prev 14:1502-1508
13. Cheatle GL (1921) Benign and malignant changes in duct epithelium of the breast. Br J Cancer 8:306
14. Clarke RB (2005) Isolation of characterization of human mammary stem cells. Cell Prolif 38:375-386
15. Clarke CA, Glaser SL, West DW, Ereman RR, Erdmann CA, Barlow JM, Wrensch MR (2002) Breast cancer incidence and mortality trends in an affuent population: Marin County, California, USA, 1990-1996. Breast Cancer Res 4:R13
16. Clarke CL, Sandle J, Jones AA, Sofronis A, Patani NR, Lakhani SR (2006a) Mapping loss of heterozygosity in normal human breast cells from BRCA1/2 carriers. Br J Cancer 95: 515-519
17. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jammison CH, Jones DL, Visvader J, Weissman IL, Wahl GM (2006b) Cancer stem cells - perspectives on current status and future directions. Cancer Res 66:9339-9344
18. Dawson FK (1933) Carcinoma in the mammary lobule and its origin. Edinb Med J 40:57-82
19. De Angelis R, Tavilla A, Verdechia A, Scoppa S, Hachey M, Feuer EJ, Mariotto AB (2009) Breast cancer survivors in the United States: geographic variability and time trends, 2005- 2015. Cancer 115:1954-1966
20. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS (1996) Loss of heterozygosity in normal tissue adjacent to breast carcinoma. Science 274:2057-2059
21. Deome KB, Faulkin IJ Jr, Bern HA, Blair PB (1959) Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res 19:515-520
22. Donnenberg VS, Donnenberg AD (2005) Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis. J Clin Pharmacol 45:872-907
23. Dooley WC (2003) Routine operative breast endoscopy during lumpectomy. Ann Surg Oncol 10:38-42
24. Easton DF, Steele L, Fields P, Orminston W, Averill D, Daly PA, McManus R, Neuhausen ST, Ford D, Wooster R, Cannon-Albright LA, Stratton MR, Goldgar DE (1997) Cancer risk in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet 61:120-128
25. Ewing J (1940) Neoplastic diseases. A treatise of tumors, 4th edn. Saunders WB, Philadelphia, p 568
26. Faverly DRG, Henricks JHCL, Holland R (2001) Breast carcinoma of limited extent. Frequency, radiologic-pathologic characteristics, and surgical margin requirements. Cancer 91:647-659
27. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371-1388
28. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jaong JH, Wolmark N (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241
29. Ford D, Easton DF, Bishop DT, Narod SA, Godgar DE (1994) Risk of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343:692-695
30. Foschini MP, Flamminio F, Miglio R, Calo DG, Cucchi MC, Masetti R, Eusebi V (2007) The impact of large sections on the study of in situ and invasive duct carcinoma of the breast. Hum Pathol 38:1736-1743
31. Gallagher S, Martin JE (1969) Early phases in the development of breast cancer. Cancer 24:1170-1178
32. Going JJ, Moffat DF (2004) Escaping from fatland: clinical and biological aspects of human mammary duct anatomy in three dimensions. J Pathol 203:538-544
33. Going JJ, Mohun TJ (2006) Human breast duct anatomy, the 'sick lobe' hypothesis and intraductal approaches to breast cancer. Breast Cancer Res Treat 97:285-291
34. Goldstein NS, Kestin LJ, Vicini FA (2007) Monomorphic epithelial proliferations. Characterization and evidence suggesting they are the pool of partially transformed lesions from which some invasive carcinomas arise. Am J Clin Pathol 128:1023-1034
35. Gudjonsson T, Magnusson MK (2005) Stem cell biology and the pathways of carcinogenesis. APMIS 113:922-929
36. Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman MC (2009) Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005). Cancer Epidemiol Biomarkers Prev 18:121-131
37. Harris JR, Lippman ME, Veronesi U, Willet W (1992) Breast cancer. N Engl J Med 327:319-328
38. Heaphy CM, Griffth JK, Bisoff M (2009) Mammary feld can-cerization: molecular evidence and clinical importance. Breast Cancer Res Treat 118:229-239
39. Hill AD, Doyle JM, McDermott EW, O'Higgins NJ (1997) Hereditary breast cancer. Br J Surg 84:1334-1339
40. Holland R, Hendricks JH, Vebeek AL, Mravunac M, Schuurmans Stekhoven JH (1990) Extent, distribution, and mammo-graphic/histological correlation of breast ductal carcinoma in situ. Lancet 335:519-522
41. Honeth G, Bendahl PO, Ringnér M, Saal LH, Gruvbenger-Saal SK, Lövgren K, Grabau D, Fernö M, Borg A, Hegardt C (2008) The CD44+/CD24- phenotype is enriched in basal-like breast tumors. Breast Cancer Res 10:R53
42. Hortobagyi GN (2005) Trastuzumab in the treatment of breast cancer. N Engl J Med 353:1734-1736
43. Howard BA, Gustersson BA (2000) Human breast development. J Mammary Gland Biol Neoplasia 5:119-137
44. Jolicoeur F, Gaboury LA, Oligny LL (2003) Basal cells of second trimester fetal breasts: immunohistochemical study of myoepithelial precursors. Pediatr Dev Pathol 6:398-413
45. Jones C, Merrett S, Thomas VA, Barker TH, Lakhani SR (2003) Comparative genomic hybridization analysis of bilateral hyperplasia of usual type of the breast. J Pathol 199:152-156
46. Kawamura T, Sobue T (2005) Comparison of breast cancer mortality in fve countries: France, Italy, Japan, the UK and the USA from the WHO mortality database (1960-2000). Jpn J Clin Oncol 35:758-759
47. Lakhani SR, Collins N, Sloane JP, Stratton MR (1995a) Loss of heterozygosity in lobular carcinoma in situ of the breast. Clin Mol Pathol 48:M74-M78
48. Lakhani SR, Collins N, Stratton MR, Sloane JP (1995b) Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosome 16q and 17p. J Clin Pathol 48:611-615
49. Lakhani SR, Slack DN, Hamoudi RA, Collins N, Stratton MR, Sloane JP (1996) Detection of allelic imbalance indicates that a proportion of mammary hyperplasia of usual type are clonal, neoplastic proliferations. Lab Invest 74:129-135
50. Lakhani SR, Chaggar R, Davies S, Jones C, Collins N, Odell C, Stratton MR, O'Hare M (1999) Genetic alterations in "normal" luminal and myoepithelial cells of the breast. J Pathol 189:496-503
51. Lányi M (1977) Differential diagnosis of microcalcifcations, X-ray flm analysis of 60 intraductal carcinoma, the triangle principle. Radiologe 17:213-216
52. Little P, Boice JD Jr (1999) Comparison of breast cancer incidence in the Massachusetts tuberculosis fuoroscopy cohort and in the Japanese atomic bomb survivors. Radiat Res 151:218-224
53. Liu S, Ginestier C, Charafe-Jauffret E, Foco H, Kleer CG, Merajver SD, Dontu G, Wisha MS (2008) BRCA1 regulates human mammary stem/progenitor cell fate. Proc Natl Acad Sci USA 105:1680-1685
54. Mai KT, Yazdi HM, Burns BF, Perkins DG (2000) Pattern of distribution of intraductal and infltrating ductal carcinoma: Three-dimensional study using serial coronal giant sections of the breast. Hum Pathol 31:464-474
55. Meng ZH, Ben Y, Li Z, Chew K, Ljung BM, Lagios MD, Dairkee SH (2004) Aberrations of breast cancer susceptibility genes occur early in sporadic breast tumors and in acquisition of breast epithelial immortalization. Genes Chromosomes Cancer 41:214-222
56. Middleton LP, Vlastos G, Mirza NQ, Eva S, Sahin AA (2002) Multicentric mammary carcinoma, evidence of monoclonal proliferation. Cancer 94:1910-1916
57. Ohtake T, Abe R, Kimijima I, Fukushima T, Tsuchiya A, Hashi K, Wakasa H (1995) Intraductal extension of primary invasive breast carcinoma treated by breast-conservative surgery. Computer graphic three-dimensional reconstruction of the mammary duct-lobular systems. Cancer 76:32-45
58. Page DL, Rogers LW, Schuyler PA, Dupont WD, Jensen RA (2002) The natural history of ductal carcinoma in situ of the breast. In: Silverstein MJ (ed) Ductal carcinoma of the breast, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 17-21
59. Ramakrishnan R, Seema AK, Badve S (2002) Morphologic changes in breast tissue with menstrual cycle. Mod Pathol 15:1348-1356
60. Reya T, Morrison SJ, Clarke MF, Weissmann IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105-111
61. Ruder EH, Dorgan JF, Kranz S, Kris-Etherton PM, Hartman TJ (2008) Examining breast cancer growth and lifetime risk factors: early life, childhood and adolescence. Clin Breast Cancer 8:334-342
62. Rudland PS (1991) Histochemical organization and cellular composition of ductal buds in developing human breast: evidence of cytochemical intermediates between epithelial and myoepithelial cells. J Histochem Cytochem 39:1471-1484
63. Russo J, Russo IH (2004) Molecular basis of breast cancer. Prevention and treatment. Springer, Berlin/Heidelberg/New York/Hong Kong/London/Milan/Paris/ Tokio
64. Sager R (1997) Expression genetics in cancer: shifting the focus from DNA to RNA. Proc Natl Acad Sci USA 94:952-955
65. Sakakura T, Ishihara A, Yatani R (1991) Tenascin in mammary gland development: from embryogenesis to carcinogenesis. Cancer Treat Res 53:383-400
66. Simpson PT, Gale T, Reis-Filho JS, Jones C, Parry S, Sloane JP, Hanby A, Pinder SE, Lee AH, Humphreys S, Ellis IO, Lakhani SR (2005) Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol 29:734-736
67. Slaughter DP, Southwick HW, Smejkal W (1953) Field cancer-ization in oral stratifed squamous epithelium: clinical implications of multicentric origin. Cancer 6:963-968
68. Smith GH, Boulanger CA (2003) Mammary epithelial stem cells transplantation and self-renewal analysis. Cell Prolif 36(Suppl 1):3-15
69. Smith RA, Duffy SW, Gabe R, Tabár L, Yen AM, Chen TH (2004) The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am 42:793-806
70. Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA (2009) Future of cancer incidence in the United States: burdens upon aging, changing nation. J Clin Oncol 27:1-10
71. Stratton MR, Collins N, Lakhani SR, Sloane JP (1995) Loss of heterozygosity in ductal carcinoma in situ of the breast. J Pathol 175:195-201
72. Tabár L, Chen HT, Yen MFA, Tot T, Tung TH, Chen LS, Chiu YH, Duffy SW, Smith RA (2004) Mammographic tumor features can predict long-term outcomes reliably in women with 1-14 mm invasive carcinoma. Cancer 101:1745-1759
73. Tabár L, Tot T, Dean PB (2007) Breast cancer. Early detection with mammography. Casting type calcifcations: sign of a subtype with deceptive features. Thieme, Stuttgart/New York
74. Tabár L, Tot T, Dean PB (2008) Crushed stone-like calcifcations: the most frequent malignant type. Thieme, Stuttgart/New York
75. Tavassoli FA, Devili P (eds) (2003) World Health Organization classifcation of tumors. Pathology & genetics. Tumors of the breast and female genital organs. IARC, Lyon, p 63
76. Teboul M, Halliwell M (1995) Atlas of ultrasound and ductal echography of the breast: the introduction of anatomic intelligence into breast imaging. Wiley-Blackwell, UK, p 380
77. The Swedish Organized Service Screening Evaluation Group (2006) Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confrma-tion with expanded data. Cancer Epidemiol Biomarkers Prev 15:45-51
78. Tot T (2005a) Correlating the ground truth of mammographic histology with the success or failure of imaging. Technol Cancer Res Treat 4:23-28
79. Tot T (2005b) DCIS, cytokeratins, and the theory of the sick lobe. Virchows Arch 447:1-8
80. Tot T (2007a) The theory of the sick breast lobe and the possible consequences. Int J Surg Pathol 15:369-375
81. Tot T (2007b) How to eradicate breast carcinomas: a hypothetical way of breast cancer prevention based on the theory of the sick lobe. In: Litchfeld JE (ed) New research in precan-cerous conditions. Nova, New York, pp 165-181
82. Tot T (2007c) The clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histological sections. Cancer 110:2551-2560
83. Tot T (2009) The metastatic capacity of multifocal breast carcinomas: extensive tumors versus tumors of limited extent. Hum Pathol 40:199-205
84. Tot T, Tabár L (2005) Radiologic-pathologic correlation of ductal carcinoma in situ of the breast using two- and three-dimensional large histologic sections. Semin Breast Dis 8:144-151
85. Tot T, Tabár L, Dean PB (2000) The pressing need for better his-tologic-mammographic correlation of the many variations in normal breast anatomy. Virchows Arch 437:338-344
86. Tot T, Tabár L, Dean PB (2002) Practical breast pathology. Thieme, Stuttgart/New York
87. Tot T, Pekár G, Hofmeyer S, Sollie T, Gere M, Tarján M (2009) The distribution of lesions in 1-14-mm invasive breast carcinomas and its relation to metastatic potential. Virchows Arch 455:109-115
88. Trichopoulos D (1990) Hypothesis: does breast cancer originate in utero? Lancet 335:939-940
89. Tsai YC, Lu Y, Nichols PW, Zlotnikow G, Jones PA, Smith HS (1996) Contiguous patches of normal human mammary epithelium derived from a single stem cell: implications for breast carcinogenesis. Cancer Res 56:402-404
90. Villadsen R (2005) In search of stem cell hierarchy in the human breast and its relevance in breast cancer evolution. APMIS 113:903-921
91. Villadsen R, Fridriksdottir AJ, Ronnov-Jenssen L, Gudjunsson T, Rank F, LaBarge MA, Bissell MJ, Petersen OW (2007) Evidence for stem cell hierarchy in the adult human breast. J Cell Biol 177:87-101
92. Wang Y, Yang J, Zheng H, Tomasek GJ, Zhang P, McKeever PE, Lee E Y, Zhu Y (2009) Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine model. Cancer Cell 15:514-526
93. Wellings SR, Jensen HM, Marcum RG (1975) An atlas of sub-gross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 55: 231-273
94. Wiechmann L, Kuerer HM (2008) The molecular journey from ductal carcinoma in situ to invasive breast cancer. Cancer 112:2130-2142
95. Wolff MS, Collman GW, Barrett JC, Huff J (1996) Breast cancer and environmental risk factors: epidemiological and experimental fndings. Annu Rev Pharmacol Toxicol 36:573-596
96. Xue F, Michels KB (2007) Intrauterine factors and risk of breast cancer: a systemic review and meta-analysis of current evidence. Lancet Oncol 8:1088-1100
97. Yan PS, Venkataramu C, Ibrahim A, Liu JC, Shen RZ, Diaz NM, Centeno B, Webel F, Leu UW, Shapiro CL, Eng C, Yeatman TJ, Huang TH (2006) Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue. Clin Cancer Res 12:6626-6636